<DOC>
	<DOCNO>NCT01293097</DOCNO>
	<brief_summary>This randomize , open label , control , parallel group study design test whether 2-day high dose atorvastatin administration PCI 30-day continuous intensive atorvastatin treatment superior usual care , term peri-PCI cardiovascular event , well 6-month prognosis . The goal set optimize protocol peri-PCI statin treatment Chinese CHD patient . Safety also observe .</brief_summary>
	<brief_title>Intensive Statin Treatment Chinese Coronary Artery Disease Patients Undergoing PCI</brief_title>
	<detailed_description>The study objective test whether 2-day high dose atorvastatin administration PCI 30-day continuous intensive atorvastatin treatment superior usual care , term peri-PCI cardiovascular event , well 6-month prognosis . 2160 patient non-ST segment elevate acute coronary syndrome ( ACS ) stable angina pectoris ( SAP ) schedule selective PCI randomize two group . The study group give atorvastatin 80 mg/d×2d PCI control group receive usual care . After angiography , patient undergo PCI procedure exclude study selection failure . After PCI procedure , study group give atorvastatin 40mg/d 30 day PCI control group receive usual care . The last visit 6 month PCI . Patients data troponin , CK-MB , Scr , CCR , ALT , AST procedure record . 1100 effective patient finally enrol . The study conduct 54 center China . Data collect 2,100 NSTE SAP patient undergo PCI . Primary outcome : MACE within 30 day PCI . Secondary outcome : Post-procedural change inflammatory biomarkers ( hs-CRP ) ; Morbidity CIN ; Proportion patient experience least AST &gt; 3ULN，ALT &gt; 3ULN CK &gt; 5ULN initiation study treatment . Proportion patient experience least AST , ALT , CK &gt; ULN initiation study treatment ; Proportion patient take reduce dose atorvastatin , withdraw study treatment , withdraw study due adverse event ; Combined endpoint death , cardiac death , myocardial infarction , heart failure , cardiac hospitalization , revascularization , cerebrovascular event within 6 month PCI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>2075 year old Patients clinical diagnosis NSTEACS ( unstable angina NSTE acute myocardial infarction ) stable angina pectoris ( SAP ) schedule selective coronary angiography Evidence personally sign date informed consent document Patients present STsegment elevation acute myocardial infarction ( STEMI ) high risk NSTEACS , warrant emergency coronary angiography : Experienced STEMI within previous 30 day Taking , need take atorvastatin 20mg/d equivalent statin ( simvastatin 20mg/d , pravastatin 40mg/d , fluvastatin 80mg/d rosuvastatin 5mg/d ) next 6 month , need take fibrates simultaneously accord investigator ' judgment . Anticipated repeat PCI within 6 month LDLC &lt; 1.8mmol/L patient without statin therapy 1 month Endstage congestive heart failure , LVEF &lt; 30 % Active hepatic disease hepatic dysfunction , AST/ALT &gt; 1.5UNL Myopathy increase creatine kinase ( CK &gt; 2 UNL ) White blood cell &lt; 4×109/L platelet &lt; 100×109/L Severe renal dysfunction ( Scr &gt; 3 mg/dl 264μmol/L ) Allergic experience serious adverse reaction HMGCoA reductase , ineligible take statin investigator 's judgment Severe aortic valve stenosis severe mitral stenosis , Obstructive hypertrophic cardiomyopathy , pericardial disease Pregnancy , lactation , child bear potential woman without effective contraception Accompanied malignant disease disease , cause life expectancy &lt; 6 month Participating interventional clinical trail use drug device Patients condition , investigator 's judgment , might increase risk subject adverse event abnormal laboratory find</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>